Hypoxic Culturing Enhances the Wound-Healing Potential of Adipose-Derived Stem Cells.
Kim WS., Sung JH.
Narrative Review, published in Adv Wound Care (New Rochelle) (2012) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Adv Wound Care (New Rochelle) (2012)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 24527300
- PMCID
- PMC3623590
- DOI
- 10.1089/wound.2011.0312
- Citations
- 8
Abstract (original English)
Background Adipose tissue is one of the richest sources of mesenchymal stem cells that exhibit an outstanding ability to regenerate skin. The problem Although the anatomical sites of adipose-derived stem cells (ASCs) in the body are relatively oxygen-deficient ( i.e. , 1%-5% oxygen content), ASCs are usually cultured under normoxic conditions, and long-term culturing of ASCs in normoxia may induce their senescence. Basic/clinical science advances The review is an overview of the cellular responses of ASCs during hypoxia, which collectively increase the wound-healing potential of ASCs. Furthermore, the mechanism of action for stimulation by hypoxia ( i.e. , a pivotal role of reactive oxygen species and related signal pathways) will be discussed. Clinical care relevance Hypoxia is a critical stimulatory factor for ASCs. Therefore, understanding the response and adaptation of ASCs to hypoxia may be invaluable for developing novel cell therapeutic strategies. Conclusion Culturing ASCs under hypoxia may uniquely benefit proliferation, stemness, migration, and growth factor secretion. Therefore, the preconditioning of ASCs by hypoxia shows a prominent wound-healing effect in clinical use.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.